secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-04-24T23:59:59+00:00
Accession:  0001628280-25-019507
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals announces 1-for-30 reverse stock split effective April 28 to regain Nasdaq bid price compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-30 ratio effective 12:01 a.m. ET on April 28, 2025; shares trade split-adjusted under XFOR.
- Outstanding shares reduced from ~173.6M to ~5.8M; no fractional shares issued, cash in lieu.
- Split intended to cure Nasdaq minimum bid price deficiency; company received extension to August 11, 2025.
- Proportional adjustments made to equity awards, options, and warrants; CUSIP changes to 98420X202.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025019507/0001628280-25-019507-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025019507/xfor-20250424.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-019507

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer